The devil is in the details
One persistent narrative across the investment industry is that quantitative strategies are all the same. We analyze the same data, read the same research and use the same concepts to identify attractive opportunities. But at Man Numeric, we believe the devil is in the details. How one adjusts and transforms that common dataset could make a significant difference to the risk and return profile created by a particular model, including differentiating between real alpha and what has become known as 'smart beta'. This paper is also accompanied by a video, recorded as part of Man Numeric's Unconventional Views series.
Conventional thinking is that all quantitative managers are the same. We analyze the same data, read the same academic research, and use the same concepts to identify attractive stocks. But the unconventional view is that the devil is in the details. How one adjusts and transforms that common dataset makes a big difference in the returns and risk profile of a particular model, including differentiating between alpha and what has become known as smart beta.
Value is the foundation on which many quantitative equity investment strategies are built. It started fundamentally with Graham and Dodd in the 1930’s and exploded quantitatively in the 1980’s and 1990’s as the data and computing power improved. Buying cheap stocks based on a particular metric such as earnings, asset value, or cash flow or even a more sophisticated value model may all seem similar to the uninitiated. But most value models have certain persistent biases. Cheap stocks usually have some warts; they tend to be lower growth, more levered, and riskier. As an investor, when you want to buy value as a concept, you are not trying to gain exposure to growth, leverage, or risk. If you can eliminate those biases, you can design a model that gets to the core of the concept without some of the toxic baggage. Yes, quantitative investing is very scientific, but there is some art involved in how you construct a particular signal.
Let’s take a look at how detailed adjustments can affect the efficacy of value models that most people would think would be highly correlated. The chart below shows the returns of five U.S. value models in increasing levels of sophistication, over the last dozen years.
Firstly, the Fama-French High minus Low portfolio1. The Fama French studies are the basis of the value orientation of many quantitative managers, but focuses solely on book to price. That has a 2.3% annual return with 8% volatility.
Then we have the Industry adjusted Earnings to Price model2. Selecting the cheapest companies based on earnings to price compared to industry peers. That has a 6% return with 10% volatility.
Now let’s look at the Barra Value3 – calculated by MSCI Barra that uses multiple indicators to measure cheapness such as sales, assets, and operating income. It has a 6.8% return and 10% volatility.
Our Proprietary Fair Value Model4 – uses industry relative valuation, with adjustments for growth, quality, and a stock’s risk. That has an 8.9% return, and 8.7% volatility.
As you can see, the returns become progressively better as the value models become more evolved. Additionally, the volatility of the models decreases as the signals are neutralized to some of their inherent biases. These effects are not just manifested in value models. We observe them in models like Momentum and Quality as well. The devil is not just in the details of how one constructs individual models, it is also relevant in how you combine the models into an overall signal to construct your portfolio.
Smart beta has gained a lot of attention in the recent years. Proponents of factor-based smart beta portfolios advocate that you gain exposure to these academically proven concepts like Value and Momentum in transparent, rules-based portfolios. However these generic factors can be cyclical, subject to periods of underperformance, and contain unwanted biases. Making detailed adjustments can help smooth out some of this volatility and perhaps make your smart beta, alpha.
1. Fama-French Factor – HML (High minus Low) is the average return on the two value portfolios minus the average return on the two growth portfolios. From Ken French Website: http://mba.tuck.dartmouth.edu/pages/faculty/ken.french/Data_Library/f-f_....
2. Industry-adjusted Earnings/Price – Normalized earnings to price on an industry-adjusted basis. Quintile spreads on the Numeric US universe (~3,000 stocks).
3. Barra Value – Quintile spreads of G2 Value on the Numeric US universe (~3,000 stocks). Source: MSCI Barra.
4. Proprietary Fair Value Model – Quintile spreads on the Numeric US universe (~3,000 stocks).
A video version of this paper is available below.Download full article
Opinions expressed are those of the author and may not be shared by all personnel of Man Group plc (‘Man’). These opinions are subject to change without notice, are for information purposes only and do not constitute an offer or invitation to make an investment in any financial instrument or in any product to which the Company and/or its affiliates provides investment advisory or any other financial services. Any organisations, financial instrument or products described in this material are mentioned for reference purposes only which should not be considered a recommendation for their purchase or sale. Neither the Company nor the authors shall be liable to any person for any action taken on the basis of the information provided. Some statements contained in this material concerning goals, strategies, outlook or other non-historical matters may be forward-looking statements and are based on current indicators and expectations. These forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update or revise any forward-looking statements. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those contained in the statements. The Company and/or its affiliates may or may not have a position in any financial instrument mentioned and may or may not be actively trading in any such securities. This material is proprietary information of the Company and its affiliates and may not be reproduced or otherwise disseminated in whole or in part without prior written consent from the Company. The Company believes the content to be accurate. However accuracy is not warranted or guaranteed. The Company does not assume any liability in the case of incorrectly reported or incomplete information. Unless stated otherwise all information is provided by the Company. Past performance is not indicative of future results.